Difference between revisions of "Comment Resolutions"
Jump to navigation
Jump to search
Line 64: | Line 64: | ||
| Public Comment | | Public Comment | ||
| n/a | | n/a | ||
− | | | + | | v2.0 is an update of v1.0 without additional public comment |
|- | |- | ||
| SPECT Ioflupane in Neurodegenerative Disease v1.1 | | SPECT Ioflupane in Neurodegenerative Disease v1.1 |
Revision as of 18:55, 7 July 2020
Comments received during Public Comment, Technical Confirmation, or during a Profile ballot, are reviewed by the originating Biomarker Committee.
Per the QIBA Process, committees record how each collected comment was resolved and those resolutions are posted here.